Radiation therapy in the elderly: More side effects and complications?

Critical Reviews in Oncology/Hematology

Volumn 71, Issue 1, 2009, Pages 70-78

  Gomez Millan, Jaime ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

Author keywords

Aged; Elderly; Radiochemotherapy; Radiotherapy; Side effects

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ASTROCYTOMA; BLOOD TOXICITY; BRAIN ATROPHY; BRAIN TUMOR; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMORBIDITY; DEMENTIA; DISEASE FREE SURVIVAL; ESOPHAGITIS; FUNCTIONAL STATUS; GASTROINTESTINAL TOXICITY; GERIATRIC ASSESSMENT; GLIOBLASTOMA; HEAD AND NECK CANCER; HEAD AND NECK TUMOR; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG NON SMALL CELL CANCER; MUCOSA INFLAMMATION; NEUTROPENIA; NONHUMAN; OVERALL SURVIVAL; PATIENT SELECTION; PERICARDITIS; PNEUMONIA; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; RADIATION PNEUMONIA; RECTUM CANCER; REVIEW; SURVIVAL TIME;

AGED; GERIATRIC ASSESSMENT; HUMANS; NEOPLASMS; RADIOTHERAPY;

EID: 67349213288     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.11.004     Document Type: Review

References (82)

1. Irminger-Finger I. Science of cancer and aging. J Clin Oncol 25 14 (2007) 1844-1851
2. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 80 7 (1997) 1273-1283
3. Yancik R., Havlik R.J., Wesley M.N., et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 6 5 (1996) 399-412
4. Bentzen S.M., and Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol 4 2 (1994) 68-80
5. Rudat V., Dietz A., Conradt C., et al. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol 43 2 (1997) 181-188
6. Baeyens A., Van Den Broecke R., Makar A., et al. Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 13 2 (2005) 347-353
7. Landuyt W., and van der Schueren E. Effect of age on the radiation-induced repopulation in mouse lip mucosa. Strahlenther Onkol 167 1 (1991) 41-45
8. Rosen E.M., Goldberg I.D., Myrick K.V., et al. Radiation survival of vascular smooth muscle cells as a function of age. Int J Radiat Biol Relat Stud Phys Chem Med 48 1 (1985) 71-79
9. Masuda K., Matsuura K., Withers H.R., et al. Age dependency of response of the mouse skin to single and multifractionated gamma irradiation. Radiother Oncol 7 2 (1986) 147-153
10. Maire J.P., Coudin B., Guerin J., et al. Neuropsychologic impairment in adults with brain tumors. Am J Clin Oncol 10 2 (1987) 156-162
11. Asai A., Matsutani M., Matsuda T., et al. Radiation-induced brain atrophy. Gan No Rinsho 35 11 (1989) 1325-1329
12. Stylopoulos L.A., George A.E., de Leon M.J., et al. Longitudinal CT study of parenchymal brain changes in glioma survivors. Am J Neuroradiol 9 3 (1988) 517-522
13. Crossen J.R., Garwood D., Glatstein E., et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 3 (1994) 627-642
14. Walker M.D., Alexander Jr. E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49 3 (1978) 333-343
15. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 9 (1993) 704-710
16. Keime-Guibert F., Chinot O., Taillandier L., et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med 356 15 (2007) 1527-1535
17. Kim J.J., and Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer 5 7 (2005) 516-525
18. Pignon T., Horiot J.C., Van den Bogaert W., et al. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 32A 12 (1996) 2075-2081
19. Chin R., Fisher R.J., Smee R.I., et al. Oropharyngeal cancer in the elderly. Int J Radiat Oncol Biol Phys 32 4 (1995) 1007-1016
20. Lusinchi A., Bourhis J., Wibault P., et al. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 18 4 (1990) 819-823
21. Allal A.S., Maire D., Becker M., et al. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 88 3 (2000) 648-652
22. Horiot J.-C. Radiation therapy and the geriatric oncology patient. J Clin Oncol 25 14 (2007) 1930-1935
23. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 9208 (2000) 949-955
24. Turaka A., Mohanti B.K., Chander S., et al. Quality of life assessment in patients above 60, below 50 years of age during and after curative radiotherapy in head and neck cancers. J Clin Oncol 24 18 Suppl (2006) 5552
25. Gloth F.M. Geriatric pain. Factors that limit pain relief and increase complications. Geriatrics 55 10 (2000) 46-8, 51-4
26. Rao A., and Cohen H.J. Symptom management in the elderly cancer patient: fatigue, pain, and depression. J Natl Cancer Inst Monogr 32 (2004) 150-157
27. Machtay M., Moughan J., Trotti A., et al. Pre-treatment and treatment related risk factors for severe late toxicity after chemo-RT for head and neck cancer: an RTOG analysis. J Clin Oncol 24 18 Suppl (2006) 5500
28. Bourhis Sr. J., Le Maitre A., Pignon J., et al. Impact of age on treatment effect in locally advanced head and neck cancer (HNC): two individual patient data meta-analyses. J Clin Oncol 24 18 Suppl (2006) 5501
29. Lee N.Y., de Arruda F.F., Puri D.R., et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 4 (2006) 966-974
30. Pacholke H.D., Amdur R.J., Morris C.G., et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 28 4 (2005) 351-358
31. Gregoire V., and Maingon P. Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice. Semin Radiat Oncol 14 2 (2004) 110-120
32. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 1 (1998) 1-9
33. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 3 (2003) 724-735
34. Bradley J.D., Hope A., El Naqa I., et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 69 4 (2007) 985-992
35. Takeda K., Nemoto K., Saito H., et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 62 3 (2005) 626-629
36. Chapet O., Kong F.M., Lee J.S., et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77 2 (2005) 176-181
37. Graham P.H., Gebski V.J., and Langlands A.O. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 31 2 (1995) 261-266
38. Krol A.D., Aussems P., Noordijk E.M., et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 2 (1996) 297-302
39. Graham M.V., Purdy J.A., Emami B., et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33 5 (1995) 993-1000
40. Hui Ming Y., Yun Fang L., Jin Ming Y., et al. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer. Radiother Oncol: J Eur Soc Therapeut Radiol Oncol 87 1 (2008) 29
41. Gauden S.J., and Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32 1 (2001) 71-79
42. Slotman B.J., Njo K.H., and Karim A.B. Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29 1 (1994) 33-37
43. Noordijk E.M., Poest Clement E., Hermans J., et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13 2 (1988) 83-89
44. Greenberg D.B., Sawicka J., Eisenthal S., et al. Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7 1 (1992) 38-45
45. Irvine D., Vincent L., Graydon J.E., et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17 5 (1994) 367-378
46. Timmerman R.D. Toxicity analysis of RTOG 0236 using stereotactic body radiation therapy to treat medically inoperable early stage lung cancer patients. Int J Radiat Oncol Biol Phys 69 3 (2007) 86
47. Pignon T., Gregor A., Schaake Koning C., et al. Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol 46 3 (1998) 239
48. Langer C.J., Hsu C., Curran W., et al. Do elderly patients (pts) with locally advanced non-small cell lung cancer (NSCLC) benefit from combined modality therapy? A secondary analysis of RTOG 94-10. Int J Radiat Oncol Biol Phys 51 3 (2001) 20
49. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 9 (1999) 2692-2699
50. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21 17 (2003) 3201-3206
51. Schild S.E., Mandrekar S.J., Jatoi A., et al. The value of combined modality therapy in elderly patients with stage III non-small cell lung cancer (NSCLC). J Clin Oncol (Meeting Abstracts) 25 18 Suppl (2007) 19503
52. Movsas B., Scott C., Sause W., et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45 5 (1999) 1143-1149
53. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 22 (1996) 1659-1664
54. Fisher B., Jeong J.H., Anderson S., et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347 8 (2002) 567-575
55. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348 9029 (1996) 708-713
56. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351 10 (2004) 963-970
57. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 10 (2004) 971-977
58. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 14 (1997) 949-955
59. Smith B.D., Haffty B.G., Hurria A., et al. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24 30 (2006) 4901-4907
60. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 4 (2008) 331-341
61. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47 1 (2000) 103-113
62. Huguenin P.U., Bitterli M., Lutolf U.M., et al. Localized prostate cancer in elderly patients. Outcome after radiation therapy compared to matched younger patients. Strahlenther Onkol 175 11 (1999) 554-558
63. Jani A.B., Parikh S.D., Vijayakumar S., et al. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology 65 6 (2005) 1157-1162
64. Liu L., Glicksman A.S., Coachman N., et al. Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 38 1 (1997) 65-71
65. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 166 3 (2001) 876-881
66. Geinitz H., Zimmermann F.B., Thamm R., et al. 3D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 76 1 (2005) 27-34
67. Bekelman J.E., Zelefsky M.J., Jang T.L., et al. Trends in the quality of external beam radiotherapy for elderly men with localized prostate cancer. J Clin Oncol 25 18 Suppl (2007) 6507
68. Herold D.M., Hanlon A.L., and Hanks G.E. Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43 3 (1999) 475-479
69. Maruyama Y., Van Nagell Jr. J.R., Utley J., et al. Radiation and small bowel complications in cervical carcinoma therapy. Radiology 112 3 (1974) 699-703
70. Hall W.H., Jani A.B., Ryu J.K., et al. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 8 1 (2005) 22-30
71. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 17 (2004) 1731-1740
72. Dobie S.A., Warren J.L., Matthews B., et al. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population. Cancer 112 4 (2008) 789-799
73. Bohac G.C., Hartshorn K., and Cheng D. Combined therapy for rectal cancer in the elderly. J Clin Oncol 25 18 Suppl (2007) 14504
74. Dolinsky C.M., Mahmoud N.N., Mick R., et al. 2178: preoperative chemoradiotherapy with 5-Fluorouracil (5-FU) Or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly. Int J Radiat Oncol Biol Phys 66 3 (2006) S308
75. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 10 (2006) 1215-1223
76. Maione P., Perrone F., Gallo C., et al. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23 28 (2005) 6865-6872
77. Balducci L., and Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 35 3 (2000) 147-154
78. Overcash J.A., Beckstead J., Extermann M., et al. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 54 2 (2005) 129-136
79. Min L.C., Elliott M.N., Wenger N.S., et al. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc 54 3 (2006) 507-511
80. Mohile S.G., Bylow K., Dale W., et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109 4 (2007) 802-810
81. Hurria A., Gupta S., Zauderer M., et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer 104 9 (2005) 1998-2005
82. Hurria A. We need a geriatric assessment for oncologists. Nat Clin Pract Oncol 3 12 (2006) 642-643